All data are based on the daily closing price as of July 18, 2024
h

Hyundai Feed

016790.KQ
0.72 USD
0.00
0.00%

Overview

Last close
0.72 usd
Market cap
135.97M usd
52 week high
10.40 usd
52 week low
0.69 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.0567
Price/Book Value
3.7373
Enterprise Value
215.76M usd
EV/Revenue
1.794
EV/EBITDA
-1.0901

Key financials

Revenue TTM
110.09M usd
Gross Profit TTM
12.24M usd
EBITDA TTM
-12.67M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
88.30M usd
Net debt
N/A usd

About

HYUNDAI FEED Inc. engages in the manufacture and sale of formulated feed. Its primary products include poultry and pig feed. The company also engages in the biopharmaceutical business. In addition, it focuses on the development and commercialization of immunotherapies for cancer. Further, the company's lead product includes oregovomab, an immunotherapy for ovarian cancer. Additionally, it is involved in the developing AR20.5, which treatment of pancreatic cancer. The company was formerly known as CANARIABIO Inc. and changed to HYUNDAI FEED Inc. on January 2024. The company was founded in 1983 and is headquartered in Seoul, South Korea.
  • Symbol
    016790.KQ
  • Exchange
    KQ
  • Isin
    KR7016790008
  • Country
    South Korea
  • Sector
    Consumer Defensive
  • Industry
    Packaged Foods
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.canariabio.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top